Home › Entities › myeloproliferative neoplasm › essential thrombocytosis

essential thrombocytosis

human disease
Class type of: myeloproliferative neoplasm, thrombogavitis Q1368780

Facts

10 properties
Instance of
rare disease, class of disease[2]
Subclass of
myeloproliferative neoplasm, thrombogavitis[3][4]
Drug or therapy used for treatment
hydroxycarbamide, ruxolitinib, anagrelide, peginterferon alfa-2a[8][9][10][11]
Genetic association
THPO, MPL, JAK2[12][13][14]
Has phenotype
thrombogavitis[16]
Health specialty
hematology[7]
ICD-9-CM
238.71[5]
NCI Thesaurus ID
C3407[6]
On focus list of Wikimedia project
WikiProject Medicine[15]
P14541
46D7Q[17]
🏷️ Also known as
en Primary Thrombocythemia en Thrombocytosis 1 en Thrombocythemia type 1 en THROMBOCYTHEMIA 1; THCYT1 en THROMBOCYTHEMIA 1 en THCYT1 en primary Thrombocytosis en essential thrombocytemia en Essential thrombocythaemia en essential thrombocythemia en essential thrombocytosis en ET en familial thrombocytosis en hemorrhagic thrombocythemia en hereditary thrombocythemia en Idiopathic thrombocythemia ar كثرة الصفيحات الأولية de Thrombozythämie de Thrombocythämie de Idiopathische hämorrhagische Thrombozythämie
🔖 Identifiers · 27
OpenAlex ID
C2781057849
Disease Ontology ID
DOID:2224
DiseasesDB
4522
EMedicine ID
206697
Encyclopedia of China (Third Edition) ID
559059
Exact match
purl.obolibrary.org, identifiers.org, www.orpha.net, www.orpha.net
Experimental Factor Ontology ID
0000479
Freebase ID
/m/03md98
GARD rare disease ID
6594
Genetics Home Reference Conditions ID
essential-thrombocythemia
ICD-10-CM
D47.3
ICD-11 ID (Foundation)
1695088249, 1735329275
Show all 27 identifiers +15
ICD-11 ID (MMS)
3B63.0
ICD-O
9962/3
KEGG ID
H01612
MeSH descriptor ID
D013920
MeSH tree code
C15.378.100.832, C15.378.140.860.800, C15.378.190.636.860.800, C15.378.463.825
MedlinePlus ID
000543
Microsoft Academic ID (discontinued)
2909959113
Mondo ID
MONDO_0008554
OMIM ID
188k (188k–615k, n=4)
Orphanet ID
71493, 3318
PatientsLikeMe condition ID
essential-thrombocythemia
UMLS CUI
C0040028, C0040028, C3277671
UniProt disease ID
DI-01538
Wellcome Collection concept ID
brpjdmuy
WikiProjectMed ID
Essential thrombocythemia

Report an error or request removal Lineage (PROV-JSON)

🔗 Connections
Drug or therapy used for treatment 4
hydroxycarbamide, anagrelide, peginterferon alfa-2a, ruxolitinib
← Medical condition treated 4
hydroxycarbamide, anagrelide, peginterferon alfa-2a, ruxolitinib
Genetic association 2
JAK2, MPL
Subclass of 2
disease, thrombogavitis
Has phenotype 1
thrombogavitis
Health specialty 1
hematology
Instance of 1
rare disease
On focus list of Wikimedia project 1
WikiProject Medicine
← Genetic association 1
MPL
Press Enter · cited answer in seconds

Summary

essential thrombocytosis is a rare disease[1].

Related Entities

disease

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . Disease Ontology. Retrieved . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . Disease Ontology. Retrieved . wikidata.org.
  5. [6] ↑ . Monarch Disease Ontology release 2018-06-29. Retrieved . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . NDF-RT. Retrieved . wikidata.org.
  8. [9] ↑ . Drug Indications Extracted from FAERS. Retrieved . wikidata.org.
  9. [10] ↑ . Drug Indications Extracted from FAERS. Retrieved . wikidata.org.
  10. [11] ↑ . Drug Indications Extracted from FAERS. Retrieved . wikidata.org.
  11. [12] ↑ . UniProt. Retrieved . wikidata.org.
  12. [13] ↑ . MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Retrieved . platform.opentargets.org. Provenance: wikidata.org.
  13. [14] ↑ . Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . Disease Ontology. Retrieved . wikidata.org.
  16. [17] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). essential thrombocytosis. Retrieved November 2, 2026, from https://4ort.xyz/entity/essential-thrombocytosis
MLA “essential thrombocytosis.” 4ort.xyz Knowledge Graph, 4ort.xyz, 2 Nov. 2026, https://4ort.xyz/entity/essential-thrombocytosis.
BibTeX @misc{4ortxyz_essential-thrombocytosis_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{essential thrombocytosis}}, year = {2026}, url = {https://4ort.xyz/entity/essential-thrombocytosis}, note = {Accessed: 2026-11-02}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): essential thrombocytosis — https://4ort.xyz/entity/essential-thrombocytosis (retrieved 2026-11-02)

Canonical URL: https://4ort.xyz/entity/essential-thrombocytosis · Last refreshed:

Edit History

Rolling log of changes to this entity's Wikidata record. Values shown reflect the current state of each edited property — follow the history link to see the precise diff for any edit.

  1. 16w ago · Nyuhn · 2026-07-10 view diff on Wikidata ↗
    P14541 → 46D7Q
    "/* wbeditentity-update:0| */ QuickStatements 3.0 [[:toollabs:qs-dev/batch/40849|batch #40849]]: ZGBK ID"
  2. 17w ago · JhealdBatch bot · 2026-07-03 view diff on Wikidata ↗
    Subclass of → myeloproliferative neoplasm, thrombogavitis
    Health specialty → hematology
    Drug or therapy used for treatment → hydroxycarbamide, ruxolitinib, anagrelide +1
    Genetic association → THPO, MPL, JAK2
    + 6 other properties edited (see Wikidata diff for full list)
    "/* wbeditentity-update:0| */ QuickStatements 3.0 [[:toollabs:qs-dev/batch/39732|batch #39732]]: rm redundant subclass"
Live feed via Wikidata EventStreams. New edits appear within minutes of being made on Wikidata.